Most Recent Articles
Thanks to a recent initiative at CHOP, patients newly diagnosed with B-cell and T-cell ALL, and lymphoblastic lymphoma, now go home on average 9 days after diagnosis — that's 3 weeks sooner than previous stays.
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than 170 patients in clinical trials that have seen a 93% remission rate.
Since its inception in October 2016, the workshop has created recommendations for the 50 most common syndromes that predispose children to cancer and produced 16 position papers.
Newly created videos allow families to see the facilities’ interiors and better understand what will happen during an outpatient visit before their scheduled appointment.
Published on in International Update
Our newly established Roberts Individualized Medical Genetics Center can coordinate a genetic testing plan that provides patients and families accurate and comprehensive test results within a few weeks.
A team of researchers at Children's Hospital of Philadelphia has innovated a new womb-like device that may dramatically reduce the effects of prematurity and revolutionize care for these tiny and vulnerable babies.
At Children’s Hospital of Philadelphia’s Bone and Soft Tissue Tumor Program, families take comfort knowing that their child’s care is in the hands of a multidisciplinary team with unmatched clinical and surgical expertise.